Epithelial–mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease

Developmental Dynamics

Volumn 247, Issue 3, 2018, Pages 346-358

  Jolly, Mohit Kumar ^a   Ward, Chris ^b   Eapen, Mathew Suji ^c   Myers, Stephen ^c   Hallgren, Oskar ^d   Levine, Herbert ^a   Sohal, Sukhwinder Singh ^c  

^a RICE UNIVERSITY   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF TASMANIA   (Australia)

^d LUND UNIVERSITY   (Sweden)

Author keywords

chronic pulmonary obstructive disease (COPD); epithelial mesenchymal transition (EMT); hybrid epithelial mesenchymal; idiopathic pulmonary fibrosis (IPF); lung cancer

Indexed keywords

ASTHMA; BASEMENT MEMBRANE; BRANCHING MORPHOGENESIS; BRONCHIOLITIS OBLITERANS; CELL ADHESION; CELL RESPIRATION; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLARA CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROSING ALVEOLITIS; GOBLET CELL; HOMEOSTASIS; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG DEVELOPMENT; LUNG DISEASE; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG GAS EXCHANGE; MEDICAL HISTORY; PRIORITY JOURNAL; REVIEW; WOUND HEALING; ANIMAL; EXTRACELLULAR MATRIX; FIBROBLAST; PATHOLOGY;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; LUNG DISEASES;

EID: 85028985989     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.24541     Document Type: Review

References (188)

1. Adamson IY, Young L, Bowden DH. 1988. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 130:377–383.
2. Alder JK, Chen JJL, Lancaster L, Danoff S, Su SC, Cogan JD, Vulto I, Xie MY, Qi XD, Tuder RM, Phillips JA, Lansdorp PM, Loyd JE, Armanios MY. 2008. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A 105:13051–13056.
3. Andriani F, Bertolini G, Facchinetti F, Baldoli E, Moro M, Casalini P, Caserini R, Milione M, Leone G, Pelosi G, Pastorino U, Sozzi G, Roz L. 2016. Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells. Mol Oncol 10:253–271.
4. Annes JP, Munger JS, Rifkin DB. 2003. Making sense of latent TGFbeta activation. J Cell Sci 116:217–224.
5. Arnoux V, Nassour M, L'Helgoualc'h A, Hipskind RA, Savagner P. 2008. Erk5 controls slug expression and keratinocyte activation during wound healing. Mol Biol Cell 19:4738–4749.
6. Aue A, Hinze C, Walentin K, Ruffert J, Yurtdas Y, Werth M, Chen W, Rabien A, Kilic E, Schulzke JD, Schumann M, Schmidt-Ott KM. 2015. A grainyhead-like 2/ovo-like 2 pathway regulates renal epithelial barrier function and lumen expansion. J Am Soc Nephrol 26:2704–2715.
7. Bagnato G, Harari S. 2015. Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev 24:102–114.
8. Banerjee B, Musk M, Sutanto EN, Yerkovich ST, Hopkins P, Knight DA, Lindsey-Temple S, Stick SM, Kicic A, Chambers DC. 2012. Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin. PLoS One 7:e52309.
9. Banjanac M, Munic Kos V, Nujic K, Vrancic M, Belamaric D, Crnkovic S, Hlevnjak M, Erakovic Haber V. 2012. Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells. Pharmacol Res 66:357–362.
10. Barnes PJ, Adcock IM. 2011. Chronic obstructive pulmonary disease and lung cancer: a lethal association. Am J Respir Crit Care Med 184:866–867.
11. Bartis D, Mise N, Mahida RY, Eickelberg O, Thickett DR. 2014. Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important? Thorax 69:760–765.
12. Bergeron C, Tulic MK, Hamid Q. 2010. Airway remodelling in asthma: from benchside to clinical practice. Can Respir J 17:e85–e93.
13. Biddle A, Gammon L, Liang X, Costea DE, Mackenzie IC. 2016. Phenotypic plasticity determines cancer stem cell therapeutic resistance in oral squamous cell carcinoma. EBioMedicine 4:138–145.
14. Bjornland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O, Malandsmo GM. 1999. S100A4 Involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 59:4702–4708.
15. Boareto M, Jolly MK, Goldman A, Pietila M, Mani SA, Sengupta S, Ben-Jacob E, Levine H, Onuchic JN. 2016. Notch-jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface 13:pii: 20151106.
16. Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D, Murphy A, Chakravarty S, Dugar S, Higgins L, Protter AA, Gauldie J. 2005. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med 171:889–898.
17. Borthwick LA, McIlroy EI, Gorowiec MR, Brodlie M, Johnson GE, Ward C, Lordan JL, Corris PA, Kirby JA, Fisher AJ. 2010. Inflammation and epithelial to mesenchymal transition in lung transplant recipients: role in dysregulated epithelial wound repair. Am J Transplant 10:498–509.
18. Borthwick LA, Parker SM, Brougham KA, Johnson GE, Gorowiec MR, Ward C, Lordan JL, Corris PA, Kirby JA, Fisher AJ. 2009. Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax 64:770–777.
19. Borthwick LA, Sunny SS, Oliphant V, Perry J, Brodlie M, Johnson GE, Ward C, Gould K, Corris PA, De Soyza A, Fisher AJ. 2011. Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway. Eur Respir J 37:1237–1247.
20. Brusselle G, Bracke K. 2014. Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease. Ann Am Thorac Soc 11(suppl 5):S322–S328.
21. Burgess JK, Mauad T, Tjin G, Karlsson JC, Westergren-Thorsson G. 2016. The extracellular matrix – the under-recognized element in lung disease? J Pathol 240:397–409.
22. Camara J, Jarai G. 2010. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis Tissue Repair 3:2.
23. Chen F, Desai TJ, Qian J, Niederreither K, Lu JN, Cardoso WV. 2007. Inhibition of Tgf beta signaling by endogenous retinoic acid is essential for primary lung bud induction. Development 134:2969–2979.
24. Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen JY, Wang ZW. 2016. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Oncotarget 7:18247–18261.
25. Chen W, Dong QH, Shin KH, Kim RH, Oh JE, Park NH, Kang MK. 2010. Grainyhead-like 2 enhances the human telomerase reverse transcriptase gene expression by inhibiting DNA methylation at the 5 ′-CpG island in normal human keratinocytes. J Biol Chem 285:40852–40863.
26. Chen YL, Lv J, Ye XL, Sun MY, Xu Q, Liu CH, Min LH, Li HP, Liu P, Ding X. 2011. Sorafenib inhibits transforming growth factor beta1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology 53:1708–1718.
27. Cholankeril G, Morais S, Swami S, Meharg J, Dubielecka P. 2016. Role of epithelial to mesenchymal transition (EMT) in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 193.
28. Cieply B, Farris J, Denvir J, Ford HL, Frisch SM. 2013. Epithelial-Mesenchymal Transition and Tumor Suppression Are Controlled by a Reciprocal Feedback Loop between ZEB1 and Grainyhead-like-2. Cancer Res 73:6299–6309.
29. Cieply B, Riley PA, Ivanov A, Pifer PM, Addison JB, Widmeyer J, Denvir J, Frisch SM. 2012. Suppression of the epithelial-mesenchymal transition (EMT) by a wound healing gene, Grainyhead-like-2. Cancer Res 72:2440–2453.
30. Comaills V, Kabeche L, Morris R, Buisson R, Yu M, Madden MW, LiCausi JA, Boukhali M, Tajima K, Pan SW, Aceto N, Sil S, Zheng Y, Sundaresan T, Yae T, Jordan NV, Miyamoto DT, Ting DT, Ramaswamy S, Haas W, Zou L, Haber DA, Maheswaran S. 2016. Genomic instability is induced by persistent proliferation of cells undergoing epithelial-to-mesenchymal transition. Cell Rep 17:2632–2647.
31. Crosby LM, Waters CM. 2010. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 298:L715–L731.
32. De Craene B, Berx G. 2013. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13:97–110.
33. de Torres JP, Marin JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, Baz-Davila R, Zulueta JJ, Aguirre-Jaime A, Saetta M, Cosio MG, Celli BR. 2011. Lung cancer in patients with chronic obstructive pulmonary disease--incidence and predicting factors. Am J Respir Crit Care Med 184:913–919.
34. DeMaio L, Buckley ST, Krishnaveni MS, Flodby P, Dubourd M, Banfalvi A, Xing Y, Ehrhardt C, Minoo P, Zhou B, Crandall ED, Borok Z. 2012. Ligand-independent transforming growth factor-beta type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition. J Pathol 226:633–644.
35. Di Carlo S, Rossi E, Politano G, Inghilleri S, Morbini P, Calabrese F, Benso A, Savino A, Cova E, Zampieri D, Meloni F. 2016. Identification of miRNAs potentially involved in bronchiolitis obliterans syndrome: a computational study. Plos One 11:e0161771.
36. Dong CF, Yuan TT, Wu YD, Wang YF, Fan TWM, Miriyala S, Lin YW, Yao J, Shi J, Kang TB, Lorkiewicz P, St Clair D, Hung MC, Evers BM, Zhou BHP. 2013. Loss of FBP1 by snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23:316–331.
37. Eapen MS, Grover R, Ahuja K, Williams A, Sohal SS. 2016. Ventilatory efficiency slope as a predictor of suitability for surgery in chronic obstructive pulmonary disease patients with lung cancer. Ann Transl Med 4:296.
38. Fan Z, Jiang H, Wang Z, Qu J. 2016. Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-beta1 by attenuating the upregulation of SphK1. Oncol Rep 36:1016–1022.
39. Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong STC, Choi H, Rayes TE, Ryu S, Troeger J, Schwabe RF, Vahdat LT, Altorki NK, Mittal V, Gao D. 2015. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527:472–476.
40. Gao X, Vockley CM, Pauli F, Newberry KM, Xue Y, Randell SH, Reddy TE, Hogan BL. 2013. Evidence for multiple roles for grainyhead-like 2 in the establishment and maintenance of human mucociliary airway epithelium. [corrected]. Proc Natl Acad Sci U S A 110:9356–9361.
41. Garber K. 2008. Epithelial-to-mesenchymal transition is important to metastasis, but questions remain. J Natl Cancer Inst 100:232–233, 239.
42. Gardner A, Fisher AJ, Richter C, Johnson GE, Moisey EJ, Brodlie M, Ward C, Krippner-Heidenreich A, Mann DA, Borthwick LA. 2012. The critical role of TAK1 in accentuated epithelial to mesenchymal transition in obliterative bronchiolitis after lung transplantation. Am J Pathol 180:2293–2308.
43. Ge LY, Habiel DM, Hansbro PM, Kim RY, Gharib SA, Edelman JD, Konigshoff M, Parimon T, Brauer R, Huang Y, Allen J, Jiang DH, Kurkciyan AA, Mizuno T, Stripp BR, Noble PW, Hogaboam CM, Chen P. 2016. miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways. JCI Insight 1:e90301.
44. Gohy ST, Hupin C, Fregimilicka C, Detry BR, Bouzin C, Chevronay HG, Lecocq M, Weynand B, Ladjemi MZ, Pierreux CE, Birembaut P, Polette M, Pilette C. 2015. Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition. Eur Respir J 45:1258–1272.
45. Goldman A, Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder PK, Sengupta S. 2015. Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nat Commun 6:6139.
46. Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. 2016. Tumor budding: the name is EMT. Partial EMT. J Clin Med 5:pii:E51.
47. Grosse-Wilde A, d'Herouel AF, McIntosh E, Ertaylan G, Skupin A, Kuestner RE, del Sol A, Walters KA, Huang S. 2015. Stemness of the hybrid epithelial/mesenchymal state in breast cancer and its association with poor survival. Plos One 10:e0126522.
48. Hackett TL. 2012. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Curr Opin Allergy Clin Immunol 12:53–59.
49. Hackett TL, Warner SM, Stefanowicz D, Shaheen F, Pechkovsky DV, Murray LA, Argentieri R, Kicic A, Stick SM, Bai TR, Knight DA. 2009. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am J Respir Crit Care Med 180:122–133.
50. Han ML, Liu MR, Wang YM, Chen X, Xu JL, Sun Y, Zhao LY, Qu HB, Fan YM, Wu CY. 2012. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PLoS One 7:e39520.
51. Hodge S, Holmes M, Banerjee B, Musk M, Kicic A, Waterer G, Reynolds PN, Hodge G, Chambers DC. 2009. Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition. Am J Transplant 9:727–733.
52. Hostettler KE, Zhong J, Tamm M, Lardinois D, Roth M. 2014. Effect of pirfenidone on TGF-β-induced pro-fibrotic effects in primary human lung cells derived from patients with idiopathic pulmonary fibrosis. Eur Respir J 44:P763.
53. Hu B, Wu Z, Phan SH. 2003. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am J Respir Cell Mol Biol 29:397–404.
54. Huang B, Jolly MK, Lu M, Tsarfaty I, Ben-Jacob E, Onuchic JN. 2015. Modeling the transitions between collective and solitary migration phenotypes in cancer metastasis. Sci Rep 5:17379.
55. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M. 2010. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101:293–299.
56. Jenkins HA, Cool C, Szefler SJ, Covar R, Brugman S, Gelfand EW, Spahn JD. 2003. Histopathology of severe childhood asthma: a case series. Chest 124:32–41.
57. Jia D, Jolly MK, Boareto M, Parsana P, Mooney SM, Pienta KJ, Levine H, Ben-Jacob E. 2015. OVOL guides the epithelial-hybrid-mesenchymal transition. Oncotarget 6:15436–15448.
58. Jiang L, Xiao L, Sugiura H, Huang X, Ali A, Kuro-o M, Deberardinis RJ, Boothman DA. 2015. Metabolic reprogramming during TGFbeta1-induced epithelial-to-mesenchymal transition. Oncogene 34:3908–3916.
59. Jolly MK, Boareto M, Huang B, Jia DY, Lu MY, Ben-Jacob E, Onuchic JN, Levine H. 2015. Implications of the hybrid epithelial/mesenchymal phenotype in metastasis. Front Oncol 5:155.
60. Jolly MK, Huang B, Lu M, Mani SA, Levine H, Ben-Jacob E. 2014. Towards elucidating the connection between epithelial-mesenchymal transitions and stemness. J R Soc Interface 11:20140962.
61. Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E, Levine H. 2016. Stability of the hybrid epithelial/mesenchymal phentoype. Oncotarget 7:27067–27084.
62. Jonsdottir HR, Arason AJ, Palsson R, Franzdottir SR, Gudbjartsson T, Isaksson HJ, Gudmundsson G, Gudjonsson T, Magnusson MK. 2015. Basal cells of the human airways acquire mesenchymal traits in idiopathic pulmonary fibrosis and in culture. Lab Invest 95:1418–1428.
63. Kalluri R, Neilson E. 2003. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776–1784.
64. Kalluri R, Weinberg R. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428.
65. Kerr JB. 2010. Functional histology / Jeffrey B. Kerr. Sydney: Mosby.
66. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA. 2006. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 103:13180–13185.
67. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, Frank JA, Brumwell AN, Wheeler SE, Kreidberg JA, Chapman HA. 2009. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 119:213–224.
68. King TE Jr, Pardo A, Selman M. 2011. Idiopathic pulmonary fibrosis. Lancet 378:1949–1961.
69. Kiri VA. 2010. Inhaled corticosteroids and lung cancer chemoprevention in chronic obstructive pulmonary disease patients: what should we make of what we observe?. Ann Respir Med 1:23–30.
70. Kiri VA, Fabbri LM, Davis KJ, Soriano JB. 2009. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Respir Med 103:85–90.
71. Knuppel L, Ishikawa Y, Aichler M, Heinzelmann K, Hatz R, Behr J, Walch A, Bachinger HP, Eickelberg O, Staab-Weijnitz CA. 2017. A novel antifibrotic mechanism of nintedanib and pirfenidone: inhibition of collagen fibril assembly. Am J Respir Cell Mol Biol 57:77–90.
72. Kurmi OP, Lam KB, Ayres JG. 2012. Indoor air pollution and the lung in low- and medium-income countries. Eur Respir J 40:239–254.
73. Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, Hara N. 1996. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 154:477–483.
74. Ladak S, Ward C, Ali S. 2016a. MiRNA-200b inhibits epithelial-mesenchymal transition in TGF-b1 induced human bronchial epithelial cells. Am J Transpl 16:723–723.
75. Ladak SS, Ali S, Ward C. 2014. The potential role of miRNA-200b in the development of Bronchiolitis obliterans syndrome. Immunology 143:171–171.
76. Ladak SS, Ward C, Ali S. 2016b. The potential role of microRNAs in lung allograft rejection. J Heart Lung Transplant 35:550–559.
77. Lee JM, Dedhar S, Kalluri R, Thompson EW. 2006. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973–981.
78. Liang SQ, Marti TM, Dorn P, Froment L, Hall SR, Berezowska S, Kocher G, Schmid RA, Peng RW. 2015. Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer. Cell Death Dis 6:e1824.
79. Lovisa S, Zeisberg M, Kalluri R. 2016. Partial epithelial-to-mesenchymal transition and other new mechanisms of kidney fibrosis. Trends Endocrinol Metab 27:681–695.
80. Lu M, Jolly MK, Levine H, Onuchic JN, Ben-Jacob E. 2013. MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc Natl Acad Sci U S A 110:18144–18149.
81. Lu M, Jolly MK, Onuchic J, Ben-Jacob E. 2014. Toward decoding the principles of cancer metastasis circuits. Cancer Res 74:4574–4587.
82. Mahmood MQ, Reid D, Ward C, Muller HK, Knight DA, Sohal SS, Walters EH. 2017a. Transforming growth factor (TGF) beta1 and Smad signalling pathways: a likely key to EMT-associated COPD pathogenesis. Respirology 22:133–140.
83. Mahmood MQ, Sohal SS, Shukla SD, Ward C, Hardikar A, Noor WD, Muller HK, Knight DA, Walters EH. 2015. Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction. Int J Chron Obstruct Pulmon Dis 10:1515–1524.
84. Mahmood MQ, Ward C, Muller HK, Sohal SS, Walters EH. 2017b. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease. Med Oncol 34:45.
85. Mangan S, Alon U. 2003. Structure and function of the feed-forward loop network motif. Proc Natl Acad Sci U S A 100:11980–11985.
86. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715.
87. Marmai C, Sutherland RE, Kim KK, Dolganov GM, Fang X, Kim SS, Jiang S, Golden JA, Hoopes CW, Matthay MA, Chapman HA, Wolters PJ. 2011. Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 301:L71–L78.
88. Milara J, Peiro T, Serrano A, Cortijo J. 2013. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax 68:410–420.
89. Milara J, Peiro T, Serrano A, Guijarro R, Zaragoza C, Tenor H, Cortijo J. 2014. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD. Pulm Pharmacol Ther 28:138–148.
90. Mooney SM, Jolly MK, Levine H, Kulkarni P. 2016. Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins. Asian J Androl 18:704–710.
91. Mooney SM, Talebian V, Jolly MK, Jia D, Gromala M, Levine H, McConkey BJ. 2017. The GRHL2/ZEB feedback loop - a key axis in the regulation of EMT in breast cancer. J Cell Biochem [Epub ahead of print].
92. Morbini P, Inghilleri S, Campo I, Oggionni T, Zorzetto M, Luisetti M. 2011. Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis. Pathol Res Pract 207:559–567.
93. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. 2008. Generation of breast cancer stem cells through epithelial-mesenchymal transition. Plos One 3:e2888.
94. Mulugeta S, Nguyen V, Russo SJ, Muniswamy M, Beers MF. 2005. A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am J Respir Cell Mol Biol 32:521–530.
95. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D. 1999. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319–328.
96. Nieto MA, Huang RY, Jackson RA, Thiery JP. 2016. Emt: 2016. Cell 166:21–45.
97. Nishioka M, Venkatesan N, Dessalle K, Mogas A, Kyoh S, Lin TY, Nair P, Baglole CJ, Eidelman DH, Ludwig MS, Hamid Q. 2015. Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients. Respir Res 16:72.
98. Nogee LM, Dunbar AE, 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. 2001. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344:573–579.
99. Nowrin K, Sohal SS, Peterson G, Patel R, Walters EH. 2014. Epithelial-mesenchymal transition as a fundamental underlying pathogenic process in COPD airways: fibrosis, remodeling and cancer. Expert Rev Respir Med 8:547–559.
100. Ojo O, Lagan AL, Rajendran V, Spanjer A, Chen L, Sohal SS, Heijink I, Jones R, Maarsingh H, Hackett TL. 2014. Pathological changes in the COPD lung mesenchyme - Novel lessons learned from in vitro and in vivo studies. Pulm Pharmacol Ther 29:121–128.
101. Parimon T, Chien J, Bryson C, McDonell M, Udris E, Au D. 2007a. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175:712–719.
102. Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH. 2007b. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175:712–719.
103. Park SM, Gaur AB, Lengyel E, Peter ME. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894–907.
104. Parker SM, Goriwiec MR, Borthwick LA, Johnson G, Ward C, Lordan JL, Corris PA, Saretzki GC, Fisher AJ. 2008. Airway epithelial cell senescence in the lung allograft. Am J Transplant 8:1544–1549.
105. Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. 2014. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther 143:225–245.
106. Petty TL. 2005. Are COPD and lung cancer two manifestations of the same disease? Chest 128:1895–1897.
107. Pyrgaki C, Liu A, Niswander L. 2011. Grainyhead-like 2 regulates neural tube closure and adhesion molecule expression during neural fold fusion. Dev Biol 353:38–49.
108. Qian YR, Guo Y, Wan HY, Fan L, Feng Y, Ni L, Xiang Y, Li QY. 2013. Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition. Oncol Rep 29:2408–2414.
109. Revenu C, Gilmour D. 2009. EMT 2.0: shaping epithelia through collective migration. Curr Opin Genet Deve 19:338–342.
110. Rho JK, Choi YJ, Lee JK, Ryoo BY, Il Na I, Yang SH, Kim CH, Lee JC. 2009. Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer 63:219–226.
111. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR. 2014. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370:2071–2082.
112. Rifat Y, Parekh V, Wilanowski T, Hislop NR, Auden A, Ting SB, Cunningham JM, Jane SM. 2010. Regional neural tube closure defined by the Grainy head-like transcription factors. Dev Biol 345:237–245.
113. Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J, Noble PW, Hogan BL. 2011. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A 108:E1475–E1483.
114. Royer PJ, Olivera-Botello G, Koutsokera A, Aubert JD, Bernasconi E, Tissot A, Pison C, Nicod L, Boissel JP, Magnan A, SysCLAD Consortium. 2016. Chronic lung allograft dysfunction: a systematic review of mechanisms. Transplantation 100:1803–1814.
115. Rudd RM, Prescott RJ, Chalmers JC, Johnston ID, Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic S. 2007. British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival. Thorax 62:62–66.
116. Scanlon VC, Sanders T. 2007. Essentials of anatomy and physiology. Philadelphia: F.A. Davis Company.
117. Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM. 2011. Targets of the tumor suppressor miR-200 in Regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 71:7670–7682.
118. Schliekelman MJ, Taguchi A, Zhu J, Dai X, Rodriguez J, Celiktas M, Zhang Q, Chin A, Wong CH, Wang H, McFerrin L, Selamat SA, Yang C, Kroh EM, Garg KS, Behrens C, Gazdar AF, Laird-Offringa IA, Tewari M, Wistuba II, Thiery JP, Hanash SM. 2015. Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. Cancer Res 75:1789–1800.
119. Senga K, Mostov KE, Mitaka T, Miyajima A, Tanimizu N. 2012. Grainyhead-like 2 regulates epithelial morphogenesis by establishing functional tight junctions through the organization of a molecular network among claudin3, claudin4, and Rab25. Mol Biol Cell 23:2845–2855.
120. Shimamura T, Imoto S, Shimada Y, Hosono Y, Niida A, Nagasaki M, Yamaguchi R, Takahashi T, Miyano S. 2011. A novel network profiling analysis reveals system changes in epithelial-mesenchymal transition. PLoS One 6:e20804.
121. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. 1997. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100:768–776.
122. Singh A, Settleman J. 2010. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29:4741–4751.
123. Snell GI, Ward C, Wilson JW, Orsida B, Williams TJ, Walters EH. 1997. Immunopathological changes in the airways of stable lung transplant recipients. Thorax 52:322–328.
124. Sohal S, Reid D, Soltani A, Ward C, Weston S, Muller H, Wood-Baker R, Walters E. 2010a. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 15:930–938.
125. Sohal S, Reid D, Soltani A, Ward C, Weston S, Muller H, Wood-Baker R, Walters E. 2011. Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res 12:130.
126. Sohal S, Walters E. 2013a. Epithelial mesenchymal transition (EMT) in small airways of COPD patients. Thorax 68:783–784.
127. Sohal S, Walters E. 2013b. Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD). Respir Res 14:120.
128. Sohal S, Ward C, Danial W, Wood-Baker R, Walters E. 2013a. Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease. Expert Rev Respir Med 7:275–288.
129. Sohal SS. 2015. Chronic obstructive pulmonary disease (COPD) and lung cancer: epithelial mesenchymal transition (EMT), the missing link? EBioMedicine 2:1578–1579.
130. Sohal SS. 2016. Endothelial to mesenchymal transition (EndMT): an active process in chronic obstructive pulmonary disease (COPD)? Respir Res 17:20.
131. Sohal SS. 2017. Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD). Respir Investig 55:104–113.
132. Sohal SS, Mahmood QM, Walters HE. 2014a. Clinical significance of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD): potential target for prevention of airway fibrosis and lung cancer. Clin Transl Med 3:33.
133. Sohal SS, Reid D, Soltani A, Ward C, Weston S, Muller HK, Wood-Baker R, Walters EH. 2010b. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 15:930–938.
134. Sohal SS, Reid D, Soltani A, Weston S, Muller HK, Wood-Baker R, Walters EH. 2013b. Changes in airway histone deacetylase2 in smokers and COPD with inhaled corticosteroids: a randomized controlled trial. PLoS One 8:e64833.
135. Sohal SS, Soltani A, Reid D, Ward C, Wills KE, Muller HK, Walters EH. 2014b. A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial-mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study. Int J Chron Obstruct Pulmon Dis 9:533–542.
136. Sohal SS, Walters EH. 2013c. Epithelial mesenchymal transition (EMT) in small airways of COPD patients. Thorax 68:783–784.
137. Sohal SS, Walters EH. 2013d. Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD). Respir Res 14:120.
138. Soltani A, Muller H, Sohal S, Reid D, Weston S, Wood-Baker R, Walters E. 2012. Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease. Histopathology 60:964–970.
139. Soltani A, Reid DW, Sohal SS, Wood-Baker R, Weston S, Muller HK, Walters EH. 2010. Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study. Respir Res 11:105.
140. Soltani A, Walters EH, Reid DW, Shukla SD, Nowrin K, Ward C, Muller HK, Sohal SS. 2016. Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD. Int J Chron Obstruct Pulmon Dis 11:2359–2367.
141. Somarelli JA, Shetler S, Jolly MK, Wang X, Bartholf Dewitt S, Hish AJ, Gilja S, Eward WC, Ware KE, Levine H, Armstrong AJ, Garcia-Blanco MA. 2016. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2. Mol Cell Biol 36:2503–2513.
142. Steiling K, van den Berge M, Hijazi K, Florido R, Campbell J, Liu G, Xiao J, Zhang XH, Duclos G, Drizik E, Si HQ, Perdomo C, Dumont C, Coxson HO, Alekseyev YO, Sin D, Pare P, Hogg JC, McWilliams A, Hiemstra PS, Sterk PJ, Timens W, Chang JT, Sebastiani P, O'Connor GT, Bild AH, Postma DS, Lam S, Spira A, Lenburg ME. 2013. A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med 187:933–942.
143. Steinestel J, Cronauer MV, Muller J, Al Ghazal A, Skowronek P, Arndt A, Kraft K, Schrader M, Schrader AJ, Steinestel K. 2013. Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection. PLoS One 8:e65189.
144. Sundararajan V, Gengenbacher N, Stemmler MP, Kleemann JA, Brabletz T, Brabletz S. 2015. The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5. Oncotarget 6:27083–27096.
145. Suwara MI, Vanaudenaerde BM, Verleden SE, Vos R, Green NJ, Ward C, Borthwick LA, Vandermeulen E, Lordan J, Van Raemdonck DE, Corris PA, Verleden GM, Fisher AJ. 2014. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation. Transpl Int 27:857–867.
146. Tanjore H, Blackwell TS, Lawson WE. 2012. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 302:L721–L729.
147. Tanjore H, Cheng DS, Degryse AL, Zoz DF, Abdolrasulnia R, Lawson WE, Blackwell TS. 2011. Alveolar epithelial cells undergo epithelial-to-mesenchymal transition in response to endoplasmic reticulum stress. J Biol Chem 286:30972–30980.
148. Tarin D, Thompson EW, Newgreen DF. 2005. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65:5996–6000; discussion 6000–6001.
149. Thompson EW, Newgreen DF, Tarin D. 2005. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65:5991–5995; discussion 5995.
150. Thomson S, Buck E, Petti F, Griffin G, Brown E, Ramnarine N, Iwata KK, Gibson N, Haley JD. 2005. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res 65:9455–9462.
151. Tripathi SC, Peters HL, Taguchi A, Katayama A, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez-Canales J, Liu H, Behrens C, Wistuba II, Ben-Jacob E, Levine H, Molldrem JJ, Hanash SM, Ostrin EJ. 2016. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proc Natl Acad Sci U S A 113:E1555–E1564.
152. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, Rosenblatt RL, Shay JW, Garcia CK. 2007. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A 104:7552–7557.
153. Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M. 1998. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 275:L1192–L1199.
154. Varma S, Cao YX, Tagne JB, Lakshminarayanan M, Li J, Friedman TB, Morell RJ, Warburton D, Kotton DN, Ramirez MI. 2012. The transcription factors grainyhead-like 2 and NK2-homeobox 1 form a regulatory loop that coordinates lung epithelial cell morphogenesis and differentiation. J Biol Chem 287:37282–37295.
155. Varma S, Mahavadi P, Sasikumar S, Cushing L, Hyland T, Rosser AE, Riccardi D, Lu JN, Kalin TV, Kalinichenko VV, Guenther A, Ramirez MI, Pardo A, Selman M, Warburton D. 2014. Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 306:L405–L419.
156. Vaughan AE, Chapman HA. 2013. Regenerative activity of the lung after epithelial injury. Biochim Biophys Acta 1832:922–930.
157. Volckaert T, Dill E, Campbell A, Tiozzo C, Majka S, Bellusci S, Langhe SP. 2011. Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury. J Clin Invest 121:4409–4419.
158. Walentin K, Hinze C, Werth M, Haase N, Varma S, Morell R, Aue A, Potschke E, Warburton D, Qiu AD, Barasch J, Purfurst B, Dieterich C, Popova E, Bader M, Dechend R, Staff AC, Yurtdas ZY, Kilic E, Schmidt-Ott KM. 2015. A Grhl2-dependent gene network controls trophoblast branching morphogenesis. Development 142:1125–1136.
159. Wang Q, Wang YS, Zhang Y, Zhang YK, Xiao W. 2015. Involvement of urokinase in cigarette smoke extract-induced epithelial-mesenchymal transition in human small airway epithelial cells. Lab Invest 95:469–479.
160. Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK. 2009. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 84:52–59.
161. Ward C, Forrest IA, Murphy DM, Johnson GE, Robertson H, Cawston TE, Fisher AJ, Dark JH, Lordan JL, Kirby JA, Corris PA. 2005a. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 60:865–871.
162. Ward C, Robertson H, Forrest IA, Lordan J, Murphy D, Dark JH, Corris PA, Jones DE, Kirby JA. 2005b. Hypothesis: epithelial-to-mesenchymal transition is a common cause of chronic allograft failure. Transplant Proc 37:977–980.
163. Ward C, Snell GI, Orsida B, Zheng L, Williams TJ, Walters EH. 1997. Airway versus transbronchial biopsy and BAL in lung transplant recipients: different but complementary. Eur Respir J 10:2876–2880.
164. Ward C, Snell GI, Zheng L, Orsida B, Whitford H, Williams TJ, Walters EH. 1998. Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection. Am J Respir Crit Care Med 158:84–91.
165. Watanabe K, Villarreal-Ponce A, Sun P, Salmans ML, Fallahi M, Andersen B, Dai X. 2014. Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. Dev Cell 29:59–74.
166. Welch-Reardon KM, Wu N, Hughes CC. 2015. A role for partial endothelial-mesenchymal transitions in angiogenesis? Arterioscler Thromb Vasc Biol 35:303–308.
167. Werth M, Walentin K, Aue A, Schonheit J, Wuebken A, Pode-Shakked N, Vilianovitch L, Erdmann B, Dekel B, Bader M, Barasch J, Rosenbauer F, Luft FC, Schmidt-Ott KM. 2010. The transcription factor grainyhead-like 2 regulates the molecular composition of the epithelial apical junctional complex. Development 137:3835–3845.
168. Whitford HM, Orsida B, Pais M, Levvey B, Ward C, Williams TJ, Kotsimbos T, Walters EH, Snell GI. 2001. Features of bronchoalveolar lavage (BAL) in lung transplant recipients (LTR) who later develop bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant 20:176.
169. Willis BC, duBois RM, Borok Z. 2006. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 3:377–382.
170. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM, Borok Z. 2005. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166:1321–1332.
171. Wollin L, Wex E, Pautsch A, Schnapp G, Hostettler KE, Stowasser S, Kolb M. 2015. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. Eur Respir J 45:1434–1445.
172. Xiang J, Fu X, Ran W, Wang Z. 2017. Grhl2 reduces invasion and migration through inhibition of TGFβ-induced EMT in gastric cancer. Oncogenesis 6:e284.
173. Xiang XY, Deng ZB, Zhuang XY, Ju SW, Mu JY, Jiang H, Zhang LF, Yan J, Miller D, Zhang HG. 2012. Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression. PLoS One 7:e50781.
174. Xu Z, Ramachandran S, Gunasekaran M, Zhou F, Trulock E, Kreisel D, Hachem R, Mohanakumar T. 2015. MicroRNA-144 dysregulates the transforming growth factor-beta signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation. J Heart Lung Transplant 34:1154–1162.
175. Yamabuki T, Takano A, Hayama S, Ishikawa N, Kato T, Miyamoto M, Ito T, Ito H, Miyagi Y, Nakayama H, Fujita M, Hosokawa M, Tsuchiya E, Kohno N, Kondo S, Nakamura Y, Daigo Y. 2007. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 67:2517–2525.
176. Yamaguchi M, Hirai S, Tanaka Y, Sumi T, Miyajima M, Mishina T, Yamada G, Otsuka M, Hasegawa T, Kojima T, Niki T, Watanabe A, Takahashi H, Sakuma Y. 2017. Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis. Lab Invest 97:232–242.
177. Yang IA, Relan V, Wright CM, Davidson MR, Sriram KB, Savarimuthu Francis MSM, Clarke BE, Duhig EE, Bowman RV, Fong KM. 2011. Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets 15:439–456.
178. Yang K, Song Y, Tang YB, Xu ZP, Zhou W, Hou LN, Zhu L, Yu ZH, Chen HZ, Cui YY. 2014. mAChRs activation induces epithelial-mesenchymal transition on lung epithelial cells. BMC Pulm Med 14:53.
179. Yang T, Chen M, Sun T. 2013. Simvastatin attenuates TGF-beta1-induced epithelial-mesenchymal transition in human alveolar epithelial cells. Cell Physiol Biochem 31:863–874.
180. Yao LL, Zhang DF, Zhao XL, Sun BC, Liu YR, Gu Q, Zhang YH, Zhao XM, Che N, Zheng YJ, Liu F, Wang Y, Meng J. 2016. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype. J Cell Mol Med 20:1673–1685.
181. Yao Z, Fenoglio S, Gao DC, Camiolo M, Stiles B, Lindsted T, Schlederer M, Johns C, Altorki N, Mittal V, Kenner L, Sordella R. 2010. TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc Natl Acad Sci U S A 107:15535–15540.
182. Yu H, Königshoff M, Jayachandran A, Handley D, Seeger W, Kaminski N, Eickelberg O. 2008. Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis. FASEB J 22:1778–1789.
183. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. 2008. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19:2282–2287.
184. Zeisberg M, Neilson EG. 2009. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429–1437.
185. Zheng L, Walters EH, Ward C, Wang N, Orsida B, Whitford H, Williams TJ, Kotsimbos T, Snell GI. 2000. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax 55:53–59.
186. Zheng L, Ward C, Snell GI, Orsida BE, Li X, Wilson JW, Williams TJ, Walters EH. 1997. Scar collagen deposition in the airways of allografts of lung transplant recipients. Am J Respir Crit Care Med 155:2072–2077.
187. Zheng XF, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R. 2015. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527:525–530.
188. Zhong Q, Zhou B, Ann DK, Minoo P, Liu Y, Banfalvi A, Krishnaveni MS, Dubourd M, Demaio L, Willis BC, Kim KJ, duBois RM, Crandall ED, Beers MF, Borok Z. 2011. Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein. Am J Respir Cell Mol Biol 45:498–509.